Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8865367rdf:typepubmed:Citationlld:pubmed
pubmed-article:8865367lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8865367lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:8865367lifeskim:mentionsumls-concept:C0003593lld:lifeskim
pubmed-article:8865367lifeskim:mentionsumls-concept:C0085202lld:lifeskim
pubmed-article:8865367lifeskim:mentionsumls-concept:C0035268lld:lifeskim
pubmed-article:8865367lifeskim:mentionsumls-concept:C1953341lld:lifeskim
pubmed-article:8865367pubmed:issue1lld:pubmed
pubmed-article:8865367pubmed:dateCreated1997-1-2lld:pubmed
pubmed-article:8865367pubmed:abstractTextLevels of plasma low density lipoproteins (LDL) are positively, and high density lipoproteins (HDL) are negatively correlated with an increased risk for atherosclerosis. The frequencies of restriction fragment length polymorphism (RFLP) of the genes for apoB, a major LDL apolipoprotein, and apoAII, a major HDL apolipoprotein, were studied in 45 Tunisian diabetics and an equal number of sex and age matched controls. Southern blot analysis of an EcoR1 apoB polymorphism and an Msp1 apo AII polymorphism indicates that there was no statistically significant difference in the incidence of different genotypes or alleles among diabetics compared to controls.lld:pubmed
pubmed-article:8865367pubmed:languageenglld:pubmed
pubmed-article:8865367pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8865367pubmed:citationSubsetIMlld:pubmed
pubmed-article:8865367pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8865367pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8865367pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8865367pubmed:statusMEDLINElld:pubmed
pubmed-article:8865367pubmed:monthJullld:pubmed
pubmed-article:8865367pubmed:issn1078-0297lld:pubmed
pubmed-article:8865367pubmed:authorpubmed-author:ChanLLlld:pubmed
pubmed-article:8865367pubmed:authorpubmed-author:FrazierMMlld:pubmed
pubmed-article:8865367pubmed:authorpubmed-author:ChamakhiSSlld:pubmed
pubmed-article:8865367pubmed:authorpubmed-author:EzzaouiaGGlld:pubmed
pubmed-article:8865367pubmed:authorpubmed-author:AremRRlld:pubmed
pubmed-article:8865367pubmed:authorpubmed-author:GhusnHHlld:pubmed
pubmed-article:8865367pubmed:issnTypePrintlld:pubmed
pubmed-article:8865367pubmed:volume93lld:pubmed
pubmed-article:8865367pubmed:ownerNLMlld:pubmed
pubmed-article:8865367pubmed:authorsCompleteYlld:pubmed
pubmed-article:8865367pubmed:pagination25-32lld:pubmed
pubmed-article:8865367pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8865367pubmed:meshHeadingpubmed-meshheading:8865367-...lld:pubmed
pubmed-article:8865367pubmed:meshHeadingpubmed-meshheading:8865367-...lld:pubmed
pubmed-article:8865367pubmed:meshHeadingpubmed-meshheading:8865367-...lld:pubmed
pubmed-article:8865367pubmed:meshHeadingpubmed-meshheading:8865367-...lld:pubmed
pubmed-article:8865367pubmed:meshHeadingpubmed-meshheading:8865367-...lld:pubmed
pubmed-article:8865367pubmed:meshHeadingpubmed-meshheading:8865367-...lld:pubmed
pubmed-article:8865367pubmed:meshHeadingpubmed-meshheading:8865367-...lld:pubmed
pubmed-article:8865367pubmed:meshHeadingpubmed-meshheading:8865367-...lld:pubmed
pubmed-article:8865367pubmed:meshHeadingpubmed-meshheading:8865367-...lld:pubmed
pubmed-article:8865367pubmed:meshHeadingpubmed-meshheading:8865367-...lld:pubmed
pubmed-article:8865367pubmed:meshHeadingpubmed-meshheading:8865367-...lld:pubmed
pubmed-article:8865367pubmed:year1996lld:pubmed
pubmed-article:8865367pubmed:articleTitleRestriction fragment length polymorphism of the human apo B and apo AII gene regions among type II diabetics.lld:pubmed
pubmed-article:8865367pubmed:affiliationDepartment of Medicine Baylor College of Medicine, Houston, TX 77030, USA.lld:pubmed
pubmed-article:8865367pubmed:publicationTypeJournal Articlelld:pubmed